Clinical trials firm saw revenue is now expected to be down 42% this year with earnings also coming in well below expectations
Fusion Antibodies
Belfast biotech firm says it is repositioning company’s service offering to best serve clients
Belfast biotech says growth is in line with expectations
Richard Buick’s 20,000 shares issued under employee share option scheme
Queen’s University spin-out is focused on the monoclonal antibody therapeutics market
Company cuts losses but increases spend in research and development in face of crisis
Northern Ireland pharma research group offering antigens on a commercial basis
Loss narrows as company expands services and introduces new technology
Northern Ireland contract research company says trading in first quarter has been satisfactory
Belfast-based contract research firm secures appoval for share placing
Company will also use funds for existing oncology work and general working capital
Clients of contract research company working on solution to coronavirus outbreak
Third quarter trading continued ‘favourable trends’, NI contract research company said
Commercial roll-out of services in six-month period lifts revenue
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices